(Q42233102)

19 October 2017

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients (English)

1 reference

19 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

María Jesús Pérez-Elías

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Ana Marín

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ana Moreno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Verónica Iglesias

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Santiago Moreno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Iñigo Corral

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

14 January 2014

1 reference

19 October 2017

Journal of NeuroVirology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

54-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420449%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13365-013-0228-0

31 May 2020

exact match

0 references

cites work

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Changing incidence of central nervous system diseases in the EuroSIDA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Clinical validation of the NeuroScreen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

The impact of HIV-associated neuropsychological impairment on everyday functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Protease inhibitor monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0228-0

HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy

21 January 2018

1 reference

12 December 2020

Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system

1 reference

12 December 2020

Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy

1 reference

12 December 2020

Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy

1 reference

12 December 2020

Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder

1 reference

12 December 2020

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020